Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCELERON PHARMA INCXLRN · Entity 15780 | Director | January 25, 2019 | January 29, 2019 |
| Alkermes plc.ALKS · Entity 2392 | Director · Director and CEO, Alkermes plc | March 02, 2026 | March 05, 2026 |
| Epizyme, Inc.EPZM · Entity 12703 | Director | May 29, 2020 | June 02, 2020 |
| NEUROCRINE BIOSCIENCES INCNBIX · Entity 2655 | Director | May 27, 2026 | May 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCELERON PHARMA INC
Report date January 25, 2019 · Filed January 29, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 32,500 |
Reported balance
After 2019-01-25 transaction · row 1
1 source rowRow 1 · 2019-01-25 · Grant · Acquired 1,250 · Balance 32,500 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $41.64 · Expires 2029-01-25 | Direct | 7,500 |
Reported balance
After 2019-01-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-01-25 · Grant · Acquired 7,500 · Balance 7,500 F1: The shares of common stock underlying this stock option award vest in full on the one year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of common stock underlying this stock option award vest in full on the one year anniversary of the grant date.
Alkermes plc.
Report date March 02, 2026 · Filed March 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Unit AwardSEC Table II · derivative / convertible security | Direct | 88,843 |
Reported balance
After 2026-03-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-02 · Grant · Acquired 88,843 · Balance 88,843 F1: Each restricted stock unit represents a contingent right to receive one ordinary share. F2: Shares subject to the restricted stock unit award vest in full on 12/31/2026 in connection with the Company's previously announced leadership transition. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one ordinary share.
F2: Shares subject to the restricted stock unit award vest in full on 12/31/2026 in connection with the Company's previously announced leadership transition.
Epizyme, Inc.
Report date May 29, 2020 · Filed June 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.55 · Expires 2030-05-28 | Direct | 14,013 |
Reported balance
After 2020-05-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-05-29 · Grant · Acquired 14,013 · Balance 14,013 F1: This option will vest in full on May 29, 2021, subject to Reporting Person's continued service as a director. In the event of a change in control of the Issuer, the option will become exercisable in full. |
Filing footnotes · ownership attribution and instrument terms
F1: This option will vest in full on May 29, 2021, subject to Reporting Person's continued service as a director. In the event of a change in control of the Issuer, the option will become exercisable in full.
NEUROCRINE BIOSCIENCES INC
Report date May 27, 2026 · Filed May 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restriced Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,567 |
Reported balance
After 2026-05-27 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-27 · Grant · Acquired 2,567 · Balance 2,567 F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2: The RSUs will vest in full on May 27, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
F2: The RSUs will vest in full on May 27, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 19, 2020 Filed May 21, 2020 22:59 UTC | NEUROCRINE BIOSCIENCES INC NBIX · Entity 2655 | GrantNon-Qualified Stock Option · Derivative | 6,018 | $0.00 Strike: $119.93 | $0.00 |
DisclosureSEC source: 0001209191-20-031499 · doc4.xml · derivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,018 Underlying: Common Stock · 6,018 shares Expires 2030-05-19 F1 · derivative.exercise_date: Option vests in 12 equal monthly installments beginning June 19, 2020. Read SEC document |
| May 14, 2020 Filed May 14, 2020 21:00 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $11.74 | $0.00 |
DisclosureSEC source: 0001127602-20-016620 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 75,000 shares Expires 2020-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| May 14, 2020 Filed May 14, 2020 21:00 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 75,000 | $15.00 | $1,125,232.50 |
DisclosureSEC source: 0001127602-20-016620 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 759,094 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.79 to $15.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 14, 2020 Filed May 14, 2020 21:00 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 75,000 | $11.74 | $880,500.00 |
DisclosureSEC source: 0001127602-20-016620 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 834,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. Read SEC document |
| May 07, 2020 Filed May 7, 2020 20:26 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $11.74 | $0.00 |
DisclosureSEC source: 0001127602-20-015769 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Ordinary Shares · 50,000 shares Expires 2020-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| May 07, 2020 Filed May 7, 2020 20:26 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 50,000 | $14.63 | $731,265.00 |
DisclosureSEC source: 0001127602-20-015769 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 759,094 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.34 to $14.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| May 07, 2020 Filed May 7, 2020 20:26 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 50,000 | $11.74 | $587,000.00 |
DisclosureSEC source: 0001127602-20-015769 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 809,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 20:22 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $11.74 | $0.00 |
DisclosureSEC source: 0001127602-20-013125 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Ordinary Shares · 50,000 shares Expires 2020-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 20:22 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 50,000 | $13.79 | $689,500.00 |
DisclosureSEC source: 0001127602-20-013125 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 759,094 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.37 to $14.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 02, 2020 Filed Apr 3, 2020 20:22 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 50,000 | $11.74 | $587,000.00 |
DisclosureSEC source: 0001127602-20-013125 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 809,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. Read SEC document |
| March 26, 2020 Filed Mar 26, 2020 20:38 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $11.74 | $0.00 |
DisclosureSEC source: 0001127602-20-012000 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Ordinary Shares · 75,000 shares Expires 2020-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| March 26, 2020 Filed Mar 26, 2020 20:38 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 75,000 | $14.36 | $1,077,225.00 |
DisclosureSEC source: 0001127602-20-012000 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 759,094 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.805 to $14.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 26, 2020 Filed Mar 26, 2020 20:38 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 75,000 | $11.74 | $880,500.00 |
DisclosureSEC source: 0001127602-20-012000 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 834,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 20:10 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $11.74 | $0.00 |
DisclosureSEC source: 0001127602-20-011504 · form4.xml · derivative · entry 5 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Ordinary Shares · 75,000 shares Expires 2020-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. F6 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 20:10 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 15,986 | $15.04 | $240,392.67 |
DisclosureSEC source: 0001127602-20-011504 · form4.xml · nonDerivative · entry 4 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 759,094 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.86 to $15.37. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 20:10 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 48,668 | $14.51 | $706,167.81 |
DisclosureSEC source: 0001127602-20-011504 · form4.xml · nonDerivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 775,080 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.86 to $14.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 20:10 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 10,346 | $13.42 | $138,867.12 |
DisclosureSEC source: 0001127602-20-011504 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 823,748 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.8601 to $13.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 20:10 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 75,000 | $11.74 | $880,500.00 |
DisclosureSEC source: 0001127602-20-011504 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 834,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/1/19. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:36 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 17,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009029 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 3/1/2017. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 3/1/2017. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:36 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 7,770 | $20.84 | $161,926.80 |
DisclosureSEC source: 0001127602-20-009029 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 759,094 Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:36 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 17,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009029 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 766,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:15 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 32,400 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007190 · form4.xml · derivative · entry 4 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,200 Underlying: Ordinary Shares · 32,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020. Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:15 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 14,386 | $20.24 | $291,172.64 |
DisclosureSEC source: 0001127602-20-007190 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 749,364 Read SEC document |
| February 21, 2020 Filed Feb 24, 2020 21:15 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 32,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-007190 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 763,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 21:15 UTC | Alkermes plc. ALKS · Entity 2392 | GrantEmployee Stock Option (Right to Buy) · Derivative | 358,466 | $0.00 Strike: $20.43 | $0.00 |
DisclosureSEC source: 0001127602-20-007190 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 358,466 Underlying: Ordinary Shares · 358,466 shares Expires 2030-02-20 F1 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/20/2021. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:12 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 8,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006023 · form4.xml · derivative · entry 6 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,750 Underlying: Ordinary Shares · 8,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:12 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 3,886 | $17.77 | $69,054.22 |
DisclosureSEC source: 0001127602-20-006023 · form4.xml · nonDerivative · entry 4 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 731,350 Read SEC document |
| February 17, 2020 Filed Feb 18, 2020 21:12 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006023 · form4.xml · nonDerivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 735,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:12 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 18,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006023 · form4.xml · derivative · entry 5 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,250 Underlying: Ordinary Shares · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/16/19. Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:12 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 8,072 | $17.77 | $143,439.44 |
DisclosureSEC source: 0001127602-20-006023 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 726,486 Read SEC document |
| February 16, 2020 Filed Feb 18, 2020 21:12 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 18,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006023 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 734,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 21:08 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $9.21 | $0.00 |
DisclosureSEC source: 0001127602-19-032831 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 100,000 shares Expires 2019-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 21:08 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 100,000 | $19.50 | $1,950,000.00 |
DisclosureSEC source: 0001127602-19-032831 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,433 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.15 to $19.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 21:08 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 100,000 | $9.21 | $921,000.00 |
DisclosureSEC source: 0001127602-19-032831 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 816,433 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. Read SEC document |
| November 08, 2019 Filed Nov 8, 2019 21:06 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 30,205 | $0.00 Strike: $9.21 | $0.00 |
DisclosureSEC source: 0001127602-19-032318 · form4.xml · derivative · entry 6 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Ordinary Shares · 30,205 shares Expires 2019-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| November 08, 2019 Filed Nov 8, 2019 21:06 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 30,205 | $19.73 | $595,826.85 |
DisclosureSEC source: 0001127602-19-032318 · form4.xml · nonDerivative · entry 4 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,433 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.25 to $20.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| November 08, 2019 Filed Nov 8, 2019 21:06 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 30,205 | $9.21 | $278,188.05 |
DisclosureSEC source: 0001127602-19-032318 · form4.xml · nonDerivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 746,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 21:06 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 69,795 | $0.00 Strike: $9.21 | $0.00 |
DisclosureSEC source: 0001127602-19-032318 · form4.xml · derivative · entry 5 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,205 Underlying: Ordinary Shares · 69,795 shares Expires 2019-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 21:06 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 69,795 | $19.81 | $1,382,618.01 |
DisclosureSEC source: 0001127602-19-032318 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,433 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.585 to $20.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| November 07, 2019 Filed Nov 8, 2019 21:06 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 69,795 | $9.21 | $642,811.95 |
DisclosureSEC source: 0001127602-19-032318 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 786,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 22:16 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $9.21 | $0.00 |
DisclosureSEC source: 0001127602-19-028953 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Ordinary Shares · 100,000 shares Expires 2019-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 22:16 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 100,000 | $21.54 | $2,153,550.00 |
DisclosureSEC source: 0001127602-19-028953 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,433 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.19 to $21.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 19, 2019 Filed Sep 23, 2019 22:16 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 100,000 | $9.21 | $921,000.00 |
DisclosureSEC source: 0001127602-19-028953 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 816,433 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 21:20 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $9.21 | $0.00 |
DisclosureSEC source: 0001127602-19-028355 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Ordinary Shares · 100,000 shares Expires 2019-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 21:20 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 100,000 | $22.68 | $2,268,220.00 |
DisclosureSEC source: 0001127602-19-028355 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,433 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.43 to $23.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 21:20 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 100,000 | $9.21 | $921,000.00 |
DisclosureSEC source: 0001127602-19-028355 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 816,433 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 21:01 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $9.21 | $0.00 |
DisclosureSEC source: 0001127602-19-028045 · form4.xml · derivative · entry 3 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Ordinary Shares · 100,000 shares Expires 2019-11-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 21:01 UTC | Alkermes plc. ALKS · Entity 2392 | SaleOrdinary Shares | 100,000 | $20.18 | $2,017,830.00 |
DisclosureSEC source: 0001127602-19-028045 · form4.xml · nonDerivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 716,433 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.91 to $20.62. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| September 05, 2019 Filed Sep 6, 2019 21:01 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 100,000 | $9.21 | $921,000.00 |
DisclosureSEC source: 0001127602-19-028045 · form4.xml · nonDerivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 816,433 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/2/18. Read SEC document |
| May 31, 2019 Filed Jun 7, 2019 20:24 UTC | Epizyme, Inc. EPZM · Entity 12703 | GrantStock Option (Right to Buy) · Derivative | 17,633 | $0.00 Strike: $13.74 | $0.00 |
DisclosureSEC source: 0000899243-19-016008 · doc4.xml · derivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,633 Underlying: Common Stock · 17,633 shares Expires 2029-05-30 F1 · derivative.exercise_date: This option will vest in full on May 31, 2020, subject to Reporting Person's continued service as a director. In the event of a change in control of the Issuer, the option will become exercisable in full. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.